Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma.
Pharmaceuticals (Basel). 2021 Mar 12;14(3):256. doi: 10.3390/ph14030256.
Pharmaceuticals (Basel). 2021.
PMID: 33809064
Free PMC article.
Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer.
Fawwaz M, Mishiro K, Arwansyah A, Nishii R, Ogawa K.
Fawwaz M, et al.
Bioimpacts. 2024;14(1):27774. doi: 10.34172/bi.2023.27774. Epub 2023 Aug 19.
Bioimpacts. 2024.
PMID: 38327635
Free PMC article.
Item in Clipboard
Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR).
Fawwaz M, Mishiro K, Nishii R, Sawazaki I, Shiba K, Kinuya S, Ogawa K.
Fawwaz M, et al.
Molecules. 2020 Jun 24;25(12):2914. doi: 10.3390/molecules25122914.
Molecules. 2020.
PMID: 32599930
Free PMC article.
Item in Clipboard
Cite
Cite